MONOCLONAL-ANTIBODY PURIFIED FACTOR-IX - VIRAL SAFETY IN PUPS

被引：0

作者：

SHAPIRO, A

BERGMAN, GE

机构：

[1] JAMES WHITCOMB RILEY HOSP CHILDREN,INDIANAPOLIS,IN 46202

[2] ARMOUR PHARMACEUT CO,COLLEGEVILLE,PA

来源：

BLOOD | 1993年 / 82卷 / 10期

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：A64 / A64

页数：1

共 50 条

[41] FACTOR-IX ACTIVITY DERIVED FROM PURIFIED PROTHROMBIN
IRWIN, JF
MAMMEN, EF
FEDERATION PROCEEDINGS, 1974, 33 (03) : 292 - 292
[42] A NEW PURIFIED FACTOR-IX CONCENTRATE (REPLENINE) - INTRODUCTION
THOMAS, DP
HAEMOPHILIA, 1995, 1 : 5 - 6
[43] FACTOR-IX ACTIVITY DERIVED FROM PURIFIED PROTHROMBIN
FOSTERIR.J
MAMMEN, EF
THROMBOSIS RESEARCH, 1974, 5 (04) : 469 - 478
[44] PHARMACOKINETIC STUDIES ON A NEW PURIFIED FACTOR-IX CONCENTRATE
THOMAS, DP
HAEMOPHILIA, 1995, 1 : 23 - 25
[45] LACK OF INHIBITOR TO MONOCLONAL-ANTIBODY PURIFIED FACTOR-VIII CONCENTRATE
LUSHER, JM
LANCET, 1990, 336 (8725): : 1249 - 1250
[46] MONOCLONAL-ANTIBODY ANALYSIS OF PURIFIED AND CELL-ASSOCIATED TISSUE FACTOR
MORRISSEY, JH
FAIR, DS
EDGINGTON, TS
THROMBOSIS RESEARCH, 1988, 52 (03) : 247 - 261
[47] Efficacy and safety of monoclonal antibody purified factor IX concentrate in haemophilia B patients undergoing surgical procedures
Shapiro, AD
White, GC
Kim, HC
Lusher, JM
Bergman, GE
HAEMOPHILIA, 1997, 3 (04) : 247 - 253
[48] IMMUNOCHEMICAL CHARACTERIZATION OF A MONOCLONAL GAMMAG4, LAMBDA HUMAN ANTIBODY TO FACTOR-IX
PIKE, IM
YOUNT, WJ
ROBERTS, HR
PURITZ, EM
BLOOD-THE JOURNAL OF HEMATOLOGY, 1972, 40 (01): : 1 - +
[49] CLINICAL-EVALUATION OF VIRAL SAFETY OF COAGULATION FACTOR-VIII AND FACTOR-IX CONCENTRATES
MANNUCCI, PM
VOX SANGUINIS, 1993, 64 (04) : 197 - 203
[50] IMMUNOCHEMICAL CHARACTERIZATION OF A HUMAN ANTIBODY TO FACTOR-IX
PIKE, IM
YOUNT, WJ
NEAL, WR
PURITZ, EM
ROBERTS, HR
FEDERATION PROCEEDINGS, 1971, 30 (02) : A339 - &

← 1 2 3 4 5 →